
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
2026-06-09 10:10:44Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Mukka Proteins Ltd is Rated Sell
2026-05-28 10:10:30Mukka Proteins Ltd is rated Sell by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
2026-05-17 10:10:27Mukka Proteins Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's present condition as of 17 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read full news articleAre Mukka Proteins Ltd latest results good or bad?
2026-05-16 19:31:30Mukka Proteins Ltd's latest financial results for Q4 FY26 present a complex picture of the company's performance. The net sales for the quarter were reported at ₹380.61 crores, reflecting a significant quarter-on-quarter decline of 41.76% from the previous quarter's exceptional sales of ₹653.50 crores. Year-on-year, net sales saw a marginal contraction of 0.25%, indicating stagnation in core operations amidst notable volatility in revenue generation over recent quarters. Despite the revenue challenges, Mukka Proteins reported a consolidated net profit of ₹20.62 crores for Q4 FY26, which represents a year-on-year increase of 51.73%. However, this figure also reflects a quarter-on-quarter decline of 13.18%. The operating profit margin, excluding other income, improved to 9.21% from 7.84% in the same quarter last year, suggesting better cost management. Nevertheless, the company's reliance on non-operating in...
Read full news article
Mukka Proteins Q4 FY26: Profit Surge Masks Operational Headwinds
2026-05-16 09:55:50Mukka Proteins Ltd., a micro-cap player in India's FMCG sector, reported a consolidated net profit of ₹20.62 crores for Q4 FY26, marking a robust 51.73% year-on-year growth despite a sequential decline of 13.18% from the previous quarter. The ₹729 crore market capitalisation company's shares have struggled post-results, trading at ₹23.60 as of May 15, down 1.46% and languishing 28.03% below their 52-week high of ₹32.79.
Read full news articleWhen is the next results date for Mukka Proteins Ltd?
2026-05-13 23:17:33The next results date for Mukka Proteins Ltd is scheduled for 15 May 2026....
Read full news article
Mukka Proteins Ltd is Rated Sell
2026-05-06 10:10:40Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Mukka Proteins Ltd is Rated Sell
2026-04-25 10:10:25Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Mukka Proteins Ltd is Rated Sell
2026-04-14 10:10:25Mukka Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 14 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 April 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.
Read full news articleBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(D) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
09-Jun-2026 | Source : BSEMukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/06/2026 inter alia to consider and approve The proposal of raising of funds by way of issuance of securities through one or more instruments either by way of Preferential Issue/Rights Issue/or any other mode as may be considered or deemed fit.
Compliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEAnnual secretarial Compliance Report as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the year ended 31st March 2026.
Announcement under Regulation 30 (LODR)-Credit Rating
26-May-2026 | Source : BSEIntimation of Credit Rating.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






